Reuters

Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...
Yahoo

GSK's three-drug inhaler wins U.S. nod for use in asthma patients

(Reuters) - GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once ...
Reuters

Glaxo's Seretide approved for wider use in Europe

LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...
FiercePharma

Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide(R) Evohaler(R) (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla ...

Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting beta2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy[1],[2] ...
FiercePharma

Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide® Evohaler® (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla ...

Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting β2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy ...